Charting the future of psychedelics
MAPS (Multidisciplinary Association for Psychedelic Studies) (maps.org) scores 84 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, Non-profit brands, Education brands, in the 92nd percentile of 19441 Healthcare brands.
MAPS (Multidisciplinary Association for Psychedelic Studies) is an American nonprofit organization founded in 1986 and headquartered in San Jose. It focuses on psychedelic research, education, and drug policy reform, aiming to end psychedelic prohibition and develop evidence-based psychedelic-assisted therapies. MAPS has played a leading role in advancing clinical research toward government approval of psychedelic treatments, particularly for mental health conditions, while also engaging in public education and advocacy for harm reduction and policy change.
| Brand Name | MAPS (Multidisciplinary Association for Psychedelic Studies) |
|---|---|
| Domain | maps.org |
| Industry | Healthcare, Non-profit |
| Founded | 1986 |
| Headquarters | San Jose |
| Main Competitors | Usona Institute (76/100), Heffter Research Institute (82/100), Beckley Foundation (76/100), Compass Pathways (86/100), Drug Policy Alliance (87/100), Johns Hopkins Center for Psychedelic and Consciousness Research (72/100) |
Moz Domain Authority 75/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #61,593 on the Tranco list of most-visited sites - strong traffic reinforces the brand's prominence to AI models.
MAPS (Multidisciplinary Association for Psychedelic Studies) has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "MAPS works to end psychedelic prohibition and unlock the healing potential of psychedelics through research, education, and advocacy." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on Facebook, Instagram, YouTube, LinkedIn, GitHub; no detected presence on X (Twitter) - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is MAPS (Multidisciplinary Association for Psychedelic Studies)?", Claude could identify the brand as of October 2026. MAPS is a nonprofit founded in 1986 by Rick Doblin that has spearheaded research into the medical and therapeutic uses of psychedelics, most notably MDMA-assisted therapy for PTSD. It has funded and run clinical trials, advocated for policy reform, and worked to legitimize psyche Best known for Pioneering MDMA-assisted psychotherapy research for PTSD and advancing psychedelic medicine through clinical trials and advocacy.
When asked "Best brands similar to MAPS (Multidisciplinary Association for Psychedelic Studies)?", Claude would recommend MAPS (Multidisciplinary Association for Psychedelic Studies) as of October 2026. MAPS is the most prominent and longstanding organization in psychedelic medicine research, so it's a natural reference point when discussing leaders in that space.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
MAPS (Multidisciplinary Association for Psychedelic Studies)'s main competitors in Healthcare: Usona Institute (76/100), Heffter Research Institute (82/100), Beckley Foundation (76/100), Compass Pathways (86/100), Drug Policy Alliance (87/100).
Sources: Brand Analyzer scan
MAPS (Multidisciplinary Association for Psychedelic Studies) is an American nonprofit organization founded in 1986 and based in San Jose. It is dedicated to psychedelic research, education, and policy reform, with the goal of ending psychedelic prohibition and developing evidence-based psychedelic-assisted therapies.
Sources: MAPS (Multidisciplinary Association for Psychedelic Studies) official site
MAPS (Multidisciplinary Association for Psychedelic Studies) has moderate AI-search visibility, scoring 62/100 on Brand Analyzer's AI visibility composite (visibility 75, trust 37, recommendation 70). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: MAPS (Multidisciplinary Association for Psychedelic Studies) official site
MAPS (Multidisciplinary Association for Psychedelic Studies) was founded in 1986. MAPS (Multidisciplinary Association for Psychedelic Studies) operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
MAPS (Multidisciplinary Association for Psychedelic Studies) is headquartered in San Jose. MAPS (Multidisciplinary Association for Psychedelic Studies) operates in the Healthcare category.
Sources: Wikidata
MAPS offers research initiatives into psychedelic-assisted therapies, educational resources and training for healthcare providers and the public, and policy advocacy efforts aimed at drug policy reform and harm reduction.
Sources: MAPS (Multidisciplinary Association for Psychedelic Studies) official site
MAPS (Multidisciplinary Association for Psychedelic Studies) scores 70/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: MAPS (Multidisciplinary Association for Psychedelic Studies) official site
MAPS (Multidisciplinary Association for Psychedelic Studies) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: MAPS (Multidisciplinary Association for Psychedelic Studies) official site
MAPS's work is used by researchers, healthcare providers, policymakers, advocates, and individuals interested in psychedelic healing and drug policy reform.
Sources: MAPS (Multidisciplinary Association for Psychedelic Studies) official site
MAPS (Multidisciplinary Association for Psychedelic Studies) scores 62/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
MAPS (Multidisciplinary Association for Psychedelic Studies) has a moderate AI-visibility profile at 62/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (75/100) and its weakest is trust (37/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #61,593 (Tranco). The main gaps holding it back: thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify MAPS (Multidisciplinary Association for Psychedelic Studies) from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to MAPS (Multidisciplinary Association for Psychedelic Studies): MAP International (84/100), MapMyRun (84/100), Marco (84/100), Marena (84/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.